Elutia (ELUT) - EV/EBITDA Multiple

Elutia Corporation - graphic logo of issuer ELUT

The Elutia Inc. (ELUT) price chart on the GURU.Markets platform demonstrates an EV/EBITDA ratio of 0.00. Elutia Inc. (ELUT) develops innovative bio-implants, including CanGaroo antibacterial envelopes designed to protect pacemakers from infection. The business relies on a niche segment of surgical materials, offsetting risks through demand in orthopedics. Production is based on ESG principles, which include bio-waste recycling and eco-friendly packaging.

ELUT Elutia Corp: Enterprise Value to Operating Income Before Depreciation in the range 11/23/2025 - 11/11/2026

Analytical breakdowns for elutia.com (ELUT)

- stock price and consensus target price:
Stock Quotes Elutia Corp|ELUT - Fair Value Consensus
- market capitalization indicators:
Market Capitalization Elutia Corporation|ELUT - Company Buyout Price
- issuer book value statistics:
Net Assets per Single Share Elutia|ELUT - Accounting Capitalization|Market Value to Book Value Ratio elutia.com|ELUT - Company Total Asset Base
- company liabilities and liquidity data:
Total Debt to Equity Ratio Elutia Inc.|ELUT - Long-Term Loans to Capital Ratio|Short-Term Debt to Equity Elutia|ELUT - Aggregate Debt Obligations|Debt to Book Value Elutia Corporation|ELUT - Company Long-Term Debts|Company Short-Term Debt Elutia|Quick Ratio elutia.com
- business earnings and investment ratios data:
ELUT - Company Net Income|Expected Profit Elutia Inc.|ELUT - Price to Earnings Multiple|Projected Price to Earnings Elutia Inc.|ELUT - Company Value to Earnings Growth Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Elutia Corporation|ELUT - Operating income before deduction of amortization|Net earnings per share (EPS TTM) Elutia|ELUT - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months elutia.com|ELUT - Earnings per share growth in current year|Expected earnings per share growth for next year Elutia Inc.
Summary company analysis:Elutia Corp (ELUT)
Manufactured products of Elutia

The EV/EBITDA multiple determines the total enterprise value of a business relative to its operating profit before interest and taxes, allowing for an assessment of asset efficiency while accounting for debt load. By analyzing the historical EV/EBITDA levels of the company, an investor can determine the degree of business overvaluation, which is critical for Elutia Inc. (ELUT) during the commercialization of its innovative CanGaroo antibacterial matrices and the implementation of FDA-approved medical devices.

Competitors of Elutia Inc.

Intuitive Surgical Inc - Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation DHR|Becton Dickinson & Co - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio steris.com STE|West Pharmaceutical Services, Inc. (WST) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Operating Income Before Depreciation BAX|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Masimo Personal Health|Stevanato Group Corp (STVN) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to EBITDA Ratio TFX (Teleflex Incorporated)|Enterprise Value to Operating Income Before Depreciation Ratio MMSI|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Envista NVST|Business Value to Operating Income Before Depreciation ICUI|XRAY: Enterprise Value to EBITDA Ratio|LMAT - EV/EBITDA Multiple|AtriCure, Inc. (ATRC) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio staar.com|NAGE (ChromaDex Corp.) - EV/EBITDA Multiple|Company Value to EBITDA ZimVie Inc ZIMV|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization AngioDynamics Corp (ANGO)|Cerus Inc - Enterprise Value to Operating Income Before Depreciation|Alpha Teknova, Inc. - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation Ratio MGRM (monogramorthopedics.com)|STSS - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Total Company Value to Operating Income Before Depreciation Ratio InfuSystem Holdings INFU|UTMD: EV/EBITDA Multiple|Company Value to EBITDA KORU Medical (KRMD)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Nyxoah S.A.|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization MBOT|Enterprise Value to EBITDA Ratio PDEX (Pro-Dex)|EV/EBITDA Multiple Zentek Ltd (ZTEK)|Milestone Scientific Corp - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation Ratio NXGL (NEXGEL Inc)|Retractable Tech - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio Harvard Bioscience Inc. HBIO|FEMY: EV/EBITDA Multiple|Meihua Medical Technologies Co., Ltd. (MHUA) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio POAI|CJMB: Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple ATRI|Total Company Value to Operating Income Before Depreciation Ratio neurometrix.com